M-tron Industries, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data M-tron Industries, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2022	FY2022	FY2023	FY2024	FY2025
Revenue	26.7	31.8	41.2	49	54.4
Research and development	2.01	2.01	2.22	2.81	3.16
Operating income	2.11	2.88	4.3	9.39	10.3
Other non-operating income	-0	-0.28	0.1	0.38	0.66
Pre-tax income	2.11	2.6	4.4	9.78	11
Income tax	0.53	0.8	0.91	2.14	2.51
Net income	1.58	1.8	3.49	7.64	8.45
EBITDA	2.6	3.55	5.1	10.4	11.4
EPS, basic	0.59	0.67	1.29	2.78	2.94
EPS, diluted	0.59	0.67	1.28	2.65	2.62
Shares, basic (weighted)	2.68	2.68	2.7	2.75	2.87
Shares, diluted (weighted)	2.68	2.68	2.73	2.88	3.23

Balance sheet

	FY2022	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	2.64	0.93	3.91	12.6	20.9
Receivables	4	5.2	4.8	6.84	6.66
Inventory	5.22	7.52	8.88	9.51	9.67
Other current assets	0.24	0.67	0.59	0.76	1.66
Total current assets	12.1	14.3	18.2	29.8	61.2
Property, plant and equipment	3.38	3.65	4.13	5.06	6.51
Lease right-of-use assets	0.22	0.15	0.1	0.01	0.22
Goodwill	0.04	0.04	0.04
Intangible assets	0.11	0.1	0.05	0.04	0.04
Other non-current assets	0.01	0.02	0.01	0	0.12
Total assets	20	19.3	24.3	36.6	68.4
Accounts payable	1.4	2.38	1.3	1.42	1.79
Accrued liabilities	1.21	1.63	2.2	3.24	1.4
Total current liabilities	3.01	4.86	4.38	5.22	4.89
Long-term debt	0.15	0.08
Lease liabilities		0.08	0.03	0	0.15
Total liabilities	3.16	4.93	4.41	5.29	5.17
Total debt	0.15	0.08
Paid-in capital		14.1	16.2	19.9	43.4
Retained earnings		0.21	3.7	11.3	19.8
Shareholders' equity	16.8	14.3	19.9	31.3	63.2
Total equity	16.8	14.3	19.9	31.3	63.2
Total liabilities and equity	20	19.3	24.3	36.6	68.4
Shares outstanding	0	2.73	2.79	2.91	3.41

Cash flow statement

	FY2022	FY2022	FY2023	FY2024	FY2025
Net income	1.58	1.8	3.49	7.64	8.45
Depreciation and amortization	0.49	0.67	0.8	0.97	1.09
Stock-based compensation	0.29	0.46	2.42	0.64	1.08
Deferred income tax	0.51	1.14	-0.78	0.21	1.48
Change in receivables	-0.05	-1.2	0.4	-2.04	0.19
Change in inventory	-0.12	-2.3	-1.37	-0.63	-0.16
Change in payables	0.2	1.85	-0.69	0.89	-0.33
Cash from operations	2.96	2.04	4.41	7.52	10.7
Capital expenditures	-1.1	-0.94	-1.28	-1.9	-2.55
Cash from investing	-1.1	-0.94	-1.28	-1.9	-2.55
Stock issued			0	3.11	0.53
Cash from financing	-1.68	-2.82	-0.14	3.11	0.14
Net change in cash	0.18	-1.71	2.99	8.73	8.25
Free cash flow	1.86	1.11	3.12	5.62	8.11
Interest paid		0.01	0.01	0.01	0.01
Income taxes paid		0.04	1.63	2.39	1.02

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $74.05 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	18.5%	Operating income / revenue.
EBITDA margin	20.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	20.9%	Pre-tax income / revenue.
Net margin	16.3%	Net income / revenue.
FCF margin	16.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	20.7%	Cash from operations / revenue.
Effective tax rate	21.7%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	8.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	7.6%	Net income / average total assets.
Return on invested capital (ROIC)	37.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	6.1%	Research and development expense / revenue.
Stock-based pay / revenue	3.9%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	4.4%	Capital expenditures / revenue.
D&A / revenue	2.0%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	11.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	19.6%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income growth, 1y	9.5%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	53.0%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	9.8%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	47.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	10.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	67.5%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	-1.1%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	57.5%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	41.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	73.5%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow growth, 1y	44.2%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	94.3%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	102.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	64.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y	87.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	52.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y	11.9%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	6.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	16.6x	Current assets / current liabilities.
Quick ratio	14.7x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	13.6x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	5.7%	Total liabilities / total assets.
Working capital	$110.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	0.0%	(Goodwill + intangible assets) / total assets.
Tangible book value	$118.7M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.46x	Revenue / average total assets.
Fixed asset turnover	7.98x	Revenue / average property, plant and equipment.
Receivables turnover	7.08x	Revenue / average receivables.
Days sales outstanding	52 days	365 x average receivables / revenue.
FCF conversion	99.6%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	21.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.72	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$13.41	Revenue / diluted weighted shares.
FCF per share	$2.18	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.77	Cash from operations / diluted weighted shares.
Book value per share	$27.32	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$27.31	Tangible book value / shares outstanding.
Cash per share	$22.15	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$321.9M	Share price x shares outstanding.
Enterprise value	$225.6M	Market cap + total debt - cash - short-term investments.
P/E	33.8x	Market cap / net income. Only when net income is positive.
P/S	5.53x	Market cap / revenue.
P/B	2.71x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.71x	Market cap / tangible book value, when positive.
P/FCF	34.0x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	26.8x	Market cap / cash from operations, when positive.
EV/Sales	3.88x	Enterprise value / revenue.
EV/EBIT	21.0x	Enterprise value / operating income, when both are positive.
EV/EBITDA	18.9x	Enterprise value / EBITDA, when both are positive.
EV/FCF	23.8x	Enterprise value / free cash flow, when both are positive.
FCF yield	2.9%	Free cash flow / market cap.
Earnings yield	3.0%	Net income / market cap (the inverse of P/E).
PEG	0.59x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was M-tron Industries, Inc.'s revenue in fiscal 2025?

M-tron Industries, Inc. reported revenue of $54.4M for fiscal 2025, 11% higher than the year before.

Was M-tron Industries, Inc. profitable in fiscal 2025?

Yes. Net income was $8.4M, a net margin of 15.5%.

How much free cash flow did M-tron Industries, Inc. generate in fiscal 2025?

Cash from operations of $10.7M minus capital expenditures of $2.6M left free cash flow of $8.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to M-tron Industries, Inc.